T/CACM 1398-2022 Active
T/CACM 1398-2022 Pathological myopia macular hemorrhage Chinese diagnosis and treatment guidelines
Abstract
Main technical content: Preface II Introduction III 1 Scope 2 Normative reference documents 3 Terms and definitions 4 Epidemiology 5 Etiology and pathogenesis 6 Symptoms 6.1 Overview 6.2 Yin deficiency with fire hyperactivity syndrome 6.3 Qi deficiency with blood stasis syndrome 6.4 Qi stagnation and blood stasis syndrome 6.5 Liver depression with fire generation syndrome 6.6 Kidney deficiency with blood stasis syndrome 7 Diagnosis 7.1 Western medical clinical classification 7.2 Clinical characteristics 7.3 Ophthalmological examination 8 Treatment 8.1 Treatment principles 8.2 Pathological myopia with retinal fissure-like hemorrhage treatment 8.3 Pathological myopia with CNV-type macular hemorrhage treatment 9 Prevention and care 9.1 Overview 9.2 Health education 9.3 Daily life Appendix A (Informative) GRADE evidence certainty grading and recommendation strength Appendix B (Informative) 2018 Myopia Macular Lesion ATN Classification System Appendix C (Informative) Summary of recommendations 10 References
General Product Information
| Document Type | Group standards |
|---|---|
| Standard Status | Active |
| Standard Code | T/CACM 1398-2022 |
| ICS | Integrated medical science and healthcare devices |
| Implement Date | 2022-06-10 |